Crowell & Moring Advises Cure Ventures in Series A Financing of Tortugas Neuroscience
Firm News | less than 1 min read | 04.21.26
Boston – April 21, 2026: Crowell & Moring advised founding investor Cure Ventures in the Series A financing of Tortugas Neuroscience, a neurology-focused biotech company.
Cure Ventures co-led the Series A round in partnership with The Column Group and AN Venture Partners. Proceeds from the financing will support Tortugas’ ongoing research and development initiatives regarding new and major neurology and neuropsychiatric disorders, including the completion of Phase 2 clinical trials for its two lead candidates.
The financing transaction was led by partner Kurt Machemer (Boston).
Read more here.
Insights
Firm News | 2 min read | 07.15.26
Washington – July 15, 2026: Crowell & Moring has added Google’s former Regulatory Affairs Counsel for Global Legislative Oversight, James Bair, as a partner and Head of Congressional Investigations in the White Collar and Regulatory Enforcement practice in Washington, D.C.
Firm News | 2 min read | 07.14.26
Supporters to Hold July 30 Prayer Vigil for Crosley Green Ahead of Parole Decision
Firm News | 2 min read | 07.08.26
Steve Raptis, Prominent Policyholder Coverage Attorney, Joins Crowell & Moring
Firm News | 2 min read | 06.30.26
Crowell & Moring Adds Antitrust and Competition Senior Counsel Ryan Marth in Minneapolis
